Positron Emission Tomography–Computed Tomography for Neurological Indications: Diagnostic Accuracy, Clinical Utility, Cost-Effectiveness, and Guidelines


( Last Updated : August 21, 2018)
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1245-000

Details

Final Biosimilar Summary Dossier Issued:

Question


  1. What is the diagnostic test accuracy of PET-CT in patients with medically refractory epileptic seizures, multiple sclerosis, or dementia?

  2. What is the clinical utility of PET-CT in patients with medically refractory epileptic seizures, multiple sclerosis, or dementia?

  3. What is the cost-effectiveness of PET-CT in patients with medically refractory epileptic seizures, multiple sclerosis, or dementia?

  4. What are the evidence-based guidelines regarding the use of PET-CT in patients with medically refractory epileptic seizures, multiple sclerosis, or dementia?


Key Message

One non-randomized study was identified regarding positron emission tomographycomputed tomography (PET-CT) in patients with dementia. In addition, one evidence-based guideline was identified regarding the use of PET-CT in patients with dementia.


Files

Positron Emission Tomography–Computed Tomography for Neurological Indications: Diagnostic Accuracy, Clinical Utility, Cost-Effectiveness, and Guidelines

Rapid Response
August 22, 2018

Related Content

  • Evidence on Medical Imaging